drugset / Trial / NCT00003195

Total-Body Irradiation, Busulfan, and Interferon Alfa Followed by Peripheral Stem Cell or Bone Marrow Transplantation in Treating Patients With Multiple Myeloma

NCT00003195

Treatment

Summary

RATIONALE: Radiation therapy uses high-energy x-rays to damage cancer cells. Drugs used in chemotherapy use different ways to stop cancer cells from dividing so they stop growing or die. Interferon alfa may interfere with the growth of cancer cells. PURPOSE: Phase II trial to study the effectiveness of total-body irradiation, busulfan, and interferon alfa followed by peripheral stem cell or bone marrow transplantation in treating patients with multiple myeloma.

Timeline

Start
1997-12
Primary completion
Completion
2000-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule
Subject interferon alfa-2b Protein / enzyme biologic Subcutaneous

Indications